Menu

ISTOCK, ART WAGER

Trump Nominates Scott Hutchins for USDA Top Scientist

A pesticide industry leader, Hutchins was formerly president of the Entomological Society of America.

Jul 18, 2018
Sukanya Charuchandra

President Donald Trump nominated Scott Hutchins, the global head of integrated field sciences for Corteva Agriscience,  the agriculture division of DowDuPont, to the role of undersecretary for research, education and economics at the US Department of Agriculture on Monday (July 16). Hutchins also serves as an adjunct professor at the University of Nebraska. 

The chief scientist position at the Department of Agriculture (USDA) has remained vacant since Trump took office. The previous nominee, Sam Clovis, the President’s campaign cochairman, pulled out of the running due to a number of controversies, according to Politico

If Hutchins is approved by the Senate, he will be the third individual with strong ties to Dow, which, in the past, has contributed to the President’s campaign fund, reports Mother Jones. His job will include planning the allocation of the USDA’s $2.9 billion budget. Hutchins has been with Dow Agrisciences, as it was known before it merged with DuPont, since earning his doctoral degree in 1987. Unlike Clovis, Hutchins has a scientific background, with his doctoral degree in entomology from Iowa State University, reports E&ENews. “His extensive background in research and commitment to sound science and data make him exceptionally qualified for this post, and I am eager to have Dr. Hutchins join the team,” Sonny Perdue, the Agriculture Secretary, says in a statement, according to E&ENews

Hutchins has been a former president for the Entomological Society of America, whose current president, Michael Parella of the University of Idaho, called Hutchins an “ideal candidate for the role,” in a statement released by the society, according to E&ENews.  

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.